Apr. 30 at 3:42 AM
$ARRXF News yesterday
Archer Materials advanced technical work toward a demonstrator quantum qubit device, including progress on qubit readout and efforts to scale carbon material growth for wafer-scale device fabrication. The company also completed the first phase of its quantum machine learning fraud detection project and is targeting a full prototype by end of 2026. Notably, Archer recorded positive net operating cash flow of
$139,000 for the quarter and ended March with no debt.
Biochip Update:
The blood potassium Biochip program reached alpha-prototype stage at clinical standard, creating the basis for beta-prototype development later this year ahead of clinical trials and commercial negotiations.
